Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00651586 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy Study of Gatifloxacin Compared With Ciprofloxacin in Patients With Acute Bacterial Corneal Ulcers
A Phase 2 study of Bacterial Keratitis and Acute Bacterial Corneal Ulcers, sponsored by Allergan.
- Completed
- Registry status
- Phase 2
- Development phase
- 129
- Enrollment target
- 2
- Study locations
NCT00651586: Completed Phase 2 study of Bacterial Keratitis and Acute Bacterial Corneal Ulcers, sponsored by Allergan.
NCT00651586 is a Phase 2 study of Bacterial Keratitis and Acute Bacterial Corneal Ulcers that has completed, run by Allergan. The registered enrollment target is 129 participants, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00651586, a Phase 2 study of Bacterial Keratitis and Acute Bacterial Corneal Ulcers, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 129 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study evaluates the safety and efficacy of gatifloxacin 0.3% ophthalmic solution compared with ciprofloxacin 0.3% ophthalmic solution in patients with acute bacterial corneal ulcers
Conditions Studied
Interventions
- DRUG Gatifloxacin 0.3% ophthalmic solution
- DRUG Ciprofloxacin 0.3% ophthalmic solution
Study Locations (2)
Texas
- - Galveston
Tamil Nadu
- - Madurai
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2003-10 |
| Est. Completion | 2005-04 |
| Phase | Phase 2 |
What the finished NCT00651586 record still lists
NCT00651586 is an interventional study that assigns participants to a tested intervention. The registered 129 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target.
The record links to 2 conditions, with Bacterial Keratitis appearing as the primary indexed condition, and to 2 interventions - of which Gatifloxacin 0.3% ophthalmic solution is the first listed.
NCT00651586 reports a single indexed study location in Texas, Tamil Nadu.
Frequently Asked Questions
What is clinical trial NCT00651586 about?
NCT00651586 is a clinical study titled "Safety and Efficacy Study of Gatifloxacin Compared With Ciprofloxacin in Patients With Acute Bacterial Corneal Ulcers". This study evaluates the safety and efficacy of gatifloxacin 0.3% ophthalmic solution compared with ciprofloxacin 0.3% ophthalmic solution in patients with acute bacterial corneal ulcers
What is the current status of trial NCT00651586?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 129 participants. The study started on 2003-10. Estimated completion is 2005-04.
What conditions does trial NCT00651586 study?
This clinical trial studies the following conditions: Bacterial Keratitis, Acute Bacterial Corneal Ulcers.
What interventions are being tested in trial NCT00651586?
The interventions under investigation include: Gatifloxacin 0.3% ophthalmic solution (DRUG), Ciprofloxacin 0.3% ophthalmic solution (DRUG).
Who is sponsoring clinical trial NCT00651586?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00651586 being conducted?
This trial has 2 study locations across Texas, Tamil Nadu. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bacterial Keratitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00651586's enrollment target sits among peer trials
129 553rd of 2000 higher than 1,448 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03619850 · 129 participants · Phase 3
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
- NCT05704361 · 129 participants · Phase 1
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
- NCT05919849 · 129 participants · Phase 1
Supporting Parents in Affirming Their Children's Experiences of Stigma
- NCT06313749 · 129 participants · NA
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia